BioNano Genomics Highlights Study Using Next-Generation Mapping for 7-Fold Improvement in Structural Variation Detection Versus NGS

January 5, 2016

NGM together with NGS will increase understanding of the human genome’s relationship with phenotypes and diseases. This data could further accelerate the wide adoption of next-generation mapping technology among genetic and biomedical researchers.
More »

Merck KGaA, Darmstadt, Germany, Pfizer and Syndax Announce Collaboration to Evaluate Combination of Avelumab and Entinostat in Ovarian Cancer

January 4, 2016

This is an exclusive agreement between the alliance and Syndax to study the combination of these two investigational agents in ovarian cancer. Syndax will be responsible for conducting the Phase Ib/II clinical trial in ovarian cancer.
More »

Navihealth Acquires Rightcare Solutions

December 17, 2015

RightCare’s proven ROI for hospitals, proprietary decision support technology, and strong team will add immediate value.
More »